---
author: lam
slug: hydronephrosis-prognosis
date: 2019-03-02
categories: ["urology"]
tags: ["prognosis", "hydronephrosis"]
reading_time: true
title: |
  Predicting Hydronephrosis Prognosis in Obstructive and Nonobstructive Cases
description: >
  Hydronephrosis is a dilatation of pyelum and/or calyces. In a pathological
  event, such condition can happen following an obstructive or nonobstructive
  causes. Differences in underlying ethiologies affects the prognosis of
  hydronephrosis. Hence the question, what prediction can we make on the
  prognosis of hydronephrosis given the information related to its underlying
  problem?  In this literature review, database from PubMed and ScienceDirect
  are used to find relevant articles.  Concurrence with malignancy, creatinine
  clearance rate, glomerular filtration rate, carbohydrate antigen 19-9, kidney
  injury molecule-1 and thickeness of renal cortices are suggested as potential
  predictors. On the other hand, not enough evidence to show the possibility of
  using haemoglobin to predict the outcome of hydronephrosis treatment.
summary: >
  Hydronephrosis is a dilatation of pyelum and/or calyces. In a pathological
  event, such condition can happen following an obstructive or nonobstructive
  causes. Differences in underlying ethiologies affects the prognosis of
  hydronephrosis. Hence the question, what prediction can we make on the
  prognosis of hydronephrosis given the information related to its underlying
  problem?  In this literature review, database from PubMed and ScienceDirect
  are used to find relevant articles.  Concurrence with malignancy, creatinine
  clearance rate, glomerular filtration rate, carbohydrate antigen 19-9, kidney
  injury molecule-1 and thickeness of renal cortices are suggested as potential
  predictors. On the other hand, not enough evidence to show the possibility of
  using haemoglobin to predict the outcome of hydronephrosis treatment.
bibliography: ref.bib
csl: ../vancouver.csl
draft: false
---



<div id="introduction" class="section level1">
<h1>Introduction</h1>
<p>Hydronephrosis is a terminology to describe dilated pelvis with or without the
involvement of its calyces, which happen due to physiological or pathological
condition.<span class="citation"><sup><a href="#ref-Mevorach2007" role="doc-biblioref">1</a></sup></span> In a physiological condition, the dilatation of
urinary tract structure can occur following certain events such as diuresis,
increased intra-abdominal pressure (e.g: straining) also by the influence of
gravity.<span class="citation"><sup><a href="#ref-Murnaghan1958" role="doc-biblioref">2</a></sup></span> Such dilatation is important to allow efficient urine
expulsion from the renal pelvis.<span class="citation"><sup><a href="#ref-Murnaghan1958" role="doc-biblioref">2</a>,<a href="#ref-Roshani2003" role="doc-biblioref">3</a></sup></span></p>
<p>However, in a pathological condition, dilatation of the urinary tract structure
is instead aggravated by either obstructive, nonobstructive or neurogenic
cause.<span class="citation"><sup><a href="#ref-Vaidyanathan2012" role="doc-biblioref">4</a>–<a href="#ref-Tran2014" role="doc-biblioref">7</a></sup></span> In women,
hydronephrosis can be found during pregnancy and pelvic organ
prolapse.<span class="citation"><sup><a href="#ref-Hui2011" role="doc-biblioref">8</a>–<a href="#ref-Nuraj2017" role="doc-biblioref">10</a></sup></span> Meanwhile, in men, hydronephrosis
may follows Benign Prostatic Obstruction and Urothelial Carcinoma.<span class="citation"><sup><a href="#ref-Riyach2014" role="doc-biblioref">11</a>,<a href="#ref-Byers2018" role="doc-biblioref">12</a></sup></span> Regardless of gender, another common cause of hydronephrosis
including renal stone, ureter stone and neurogenic bladder.<span class="citation"><sup><a href="#ref-Vaidyanathan2012" role="doc-biblioref">4</a>,<a href="#ref-Choi2015" role="doc-biblioref">5</a></sup></span>. To a lesser degree, hydronephrosis can also be induced by
infection, drug administration as well as radiotherapy.<span class="citation"><sup><a href="#ref-Lojanapiwat2002" role="doc-biblioref">13</a>–<a href="#ref-Orchard2016" role="doc-biblioref">15</a></sup></span> Therefore, complaints related to hydronephrosis may
vary, depending on the underlying cause.</p>
<p>Diagnosis of hydronephrosis can be done through careful clinical investigation
and USG screening.<span class="citation"><sup><a href="#ref-Nuraj2017" role="doc-biblioref">10</a></sup></span> Grading of hydronephrosis can be made
subservient to the grading system proposed by Society for Fetal Urology
(SFU).<span class="citation"><sup><a href="#ref-Fernbach1993" role="doc-biblioref">16</a></sup></span> This grading system delineates five distinctive grade,
with grade 0 being normal condition and grade 4 is the severe finding.</p>
<p>Without addressing the etiological cause of hydronephrosis, managing such
cases would prove unwieldy. The recurrence of hydronephrosis is highly related
to the source of obstruction or peristaltic disturbances.<span class="citation"><sup><a href="#ref-Jespersen2005" role="doc-biblioref">17</a>–<a href="#ref-Chiancone2017" role="doc-biblioref">19</a></sup></span> Furthermore, if the case of hydronephrosis is not
well treated, it may cause irreversible structural changes. These changes may
possibly deteriorate renal function.<span class="citation"><sup><a href="#ref-Marchini2016" role="doc-biblioref">20</a>,<a href="#ref-Balikci2015" role="doc-biblioref">21</a></sup></span> The presence
of hydronephrosis is also crucial in determining the prognosis and disease
progression.<span class="citation"><sup><a href="#ref-Patel2014" role="doc-biblioref">22</a>–<a href="#ref-Luo2013" role="doc-biblioref">24</a></sup></span></p>
<p>Therefore, can we delineate each factor that may contribute to determining the
prognosis of hydronephrosis cases? In this literature review, such query shall
be challenged by current advancement in hydronephrosis understanding.</p>
</div>
<div id="method" class="section level1">
<h1>Method</h1>
<p>Thorough literature search is done using PubMed and ScienceDirect. Keywords
being used in PubMed including “Hydronephrosis [MeSH]”, “Prognosis [MesH]”,
“Urogenital System [MeSH]”, “Obstruction”, “Congestion”, “Blockage” and
“Restriction”. In the query, “Pyonephritis [MeSH]” is excluded from the result,
then “Homo sapiens” as well as “Adult [MeSH]” are being set as filters. In
ScienceDirect, keywords being used are “Hydronephrosis”, “Treatment” and
“Prognosis”. Filter being applied in this query only includes review article as
desired output.</p>
<p>Selecting articles published during the last five years, 43 results
were obtained, which then manually screened by reading the abstract and the
full paper. Afterwards, 11 articles were selected as main references. From such
articles, relevant citations were also thoroughly examined to include any
important findings and case reports.</p>
</div>
<div id="discussion" class="section level1">
<h1>Discussion</h1>
<div id="renal-physiology" class="section level2">
<h2>Renal Physiology</h2>
<p>In this part, we may want to shift our focus on two main physiological changes
which occur during hydronephrosis. This part explains the nature of glomerulus
filtration process as well as peristaltic movement in urinary tract.</p>
<div id="glomerulus-filtration" class="section level3">
<h3>Glomerulus Filtration</h3>
<p>Represented by the Glomerular Filtration Rate (GFR), the flow of plasma through
glomerulus over certain period of time defines renal function. Maintaining the
GFR requires careful regulation of the Renal Perfusion Pressure
(RPP),<span class="citation"><sup><a href="#ref-Koeppen2013" role="doc-biblioref">25</a></sup></span> where as we shall see in later section decrease of such
pressure will negatively affect the GFR.<span class="citation"><sup><a href="#ref-Carlstrom2015" role="doc-biblioref">26</a></sup></span></p>
</div>
<div id="peristaltic-movement" class="section level3">
<h3>Peristaltic Movement</h3>
<p>Urinary tract peristalsis occur due to the activity of myogenic contraction as
well as prostaglandin and neurpeptide release to maintain such
contractility.<span class="citation"><sup><a href="#ref-Nguyen2016" role="doc-biblioref">27</a>,<a href="#ref-Davidson2000" role="doc-biblioref">28</a></sup></span> Myogenic contraction is first
initiated by propagation of action potential through the activation of atypical
smooth muscle cell as a pacemaker, located proximal to pelviocalyceal region.
Electrical signal produced by the aforementioned cell elicit the activity of
adjacent muscular region of renal pelvis. Such electrical activity is then
propagated to the ureter, enabling peristalsis of urinary tract.<span class="citation"><sup><a href="#ref-Davidson2000" role="doc-biblioref">28</a></sup></span>
To maintain the peristaltic movement, recent finding suggests the importance of
prostaglandin and neuropeptide secretion.<span class="citation"><sup><a href="#ref-Nguyen2016" role="doc-biblioref">27</a></sup></span> Release of such
substances firstly started by stimulation of primary sensory nerves which then
release inotropic and chronotropic agents. These agents induce the secretion of
tachykinines and Calcitonin Gene-Related Peptide (CGRP), which act in opposite
manner. Tachykinine acts as an excitatory component to induce the release of
inotropic and chronotropic agents, while CGRP plays a role as inhibitoric of
such agents to be secreted.<span class="citation"><sup><a href="#ref-Nguyen2016" role="doc-biblioref">27</a></sup></span> Production of prostaglandin and
neuropeptide helps to regulate intracellular Ca<sup>2+</sup> concentration, thus
maintaining peristalsis.<span class="citation"><sup><a href="#ref-Nguyen2016" role="doc-biblioref">27</a></sup></span></p>
</div>
</div>
<div id="pathophysiology-in-hydronephrosis" class="section level2">
<h2>Pathophysiology in Hydronephrosis</h2>
<p>Being elucidated in this paper are two possible pathways to develop
hydronephrosis in adult. Being the most prevalent one, obstructive
hydronephrosis shall be on the spotlight, where the pathogenesis, nephron
feedback response and anatomical source of obstruction are elaborated.
In nonobstructive hydronephrosis part, the contribution of vesicoureteral
reflux as well as upper and lower motor neuron are further described.</p>
<div id="obstructive-hydronephrosis" class="section level3">
<h3>Obstructive Hydronephrosis</h3>
<p>Relative to the rate of urine production, inadequate urine drainage due to
urinary tract blockage can cause hydronephrosis. During acute settings within
6-48 hours, increased pressure is followed by increasing intraparenchymal
vascular resistance, which will subside after 48 hours. However, prolonged
state of hydronephrosis may lead into diminution of arteriovena circulation,
hence provoking renal injury, fibrous tissue formation and tubular
atrophy.<span class="citation"><sup><a href="#ref-Murnaghan1958" role="doc-biblioref">2</a>,<a href="#ref-Byers2018" role="doc-biblioref">12</a></sup></span></p>
<p>The increase of pressure may also further decrease GFR by the modulation of
myogenic vasoconstriction response and Macula Densa-Tubuloglomerular Feedback
(MD-TGF) response. Increased pressure causes vascular smooth muscle stretching,
which will activate mechanotransduction pathway. Activation of such pathway
elicit membrane depolarization, thus inducing Ca<sup>2+</sup> ion release in cytosol.
The presence of Ca<sup>2+</sup> mediates the detachment of tropomyosin from myosin,
hence enabling myosin to bind actin.<span class="citation"><sup><a href="#ref-AitchisonSmith2018" role="doc-biblioref">29</a></sup></span> Adhesion of myosin
into actin further cause muscular contraction, and therefore vasoconstriction
of the afferent arteriol. On the other hand, increased Renal Perfusion Pressure
also affect signal transduction to Macula Densa. This transduction is also
directly cause an adjustment of afferent arteriol
vasoconstriction.<span class="citation"><sup><a href="#ref-Carlstrom2015" role="doc-biblioref">26</a></sup></span></p>
<p>Source of obstructive problem can arise in either the ureter, bladder or
urethra. Within ureter, stone formation is the most probable cause of
obstruction,<span class="citation"><sup><a href="#ref-Byers2018" role="doc-biblioref">12</a></sup></span> followed by malignant and benign mass compression.
Cause of bladder obstruction could be due to urothelial carcinoma, which should
be considered in older patients with haematuria.<span class="citation"><sup><a href="#ref-Zambon2018" role="doc-biblioref">6</a>,<a href="#ref-Byers2018" role="doc-biblioref">12</a></sup></span>
Obstruction of the urethra including those of functional, benign and malignant
origin, with Benign Prostatic Hyperplasia being the most prevalent case in
older male.<span class="citation"><sup><a href="#ref-Byers2018" role="doc-biblioref">12</a></sup></span></p>
</div>
<div id="nonobstructive-hydronephrosis" class="section level3">
<h3>Nonobstructive Hydronephrosis</h3>
<p>The case of hydronephrosis due to nonobstructive origin is related with nervous
function and peristaltic movement. In such cases, the event of vesicoureteral
reflux may explain the dilated pelvis and calyces. In a study by Aboutaleb, et
al., vesicoureteral reflux degree is found to be correlated with the degree of
hydronephrosis.<span class="citation"><sup><a href="#ref-Aboutaleb2003" role="doc-biblioref">30</a></sup></span></p>
<p>Hydronephrosis is also a possible occurrence in an upper motor neuron diseases.
Twenty percent of adult with cerebral palsy in a study by Cotter, et al. is
also diagnosed as having hydronephrosis.<span class="citation"><sup><a href="#ref-Cotter2016" role="doc-biblioref">31</a></sup></span> Similarly, this case can
also be found in a spinal cord injury with inadequate neurogenic bladder
management.<span class="citation"><sup><a href="#ref-Downs2014" role="doc-biblioref">32</a></sup></span> Problem in upper motor neuron may lead to detrussor
sphincter dyssinergia (DSD), causing a bladder outlet obstruction due to
abnormal detrussor muscle contractility and involuntary sphincter
activation.<span class="citation"><sup><a href="#ref-Stoffel2016" role="doc-biblioref">33</a></sup></span> Therefore, the presence of upper motor neuron-related
neurogenic bladder can precipitate hydronephrosis.<span class="citation"><sup><a href="#ref-Gormley2010" role="doc-biblioref">34</a></sup></span></p>
</div>
</div>
<div id="management-of-urinary-retention" class="section level2">
<h2>Management of Urinary Retention</h2>
<p>The key point of hydronephrosis management is to release the tension due to
increased pressure following urinary retention.<span class="citation"><sup><a href="#ref-Stoffel2017" role="doc-biblioref">35</a></sup></span> Several
approaches can be done to attain the objective, for instances by catheterising
the patient, placing ureteral stent, performing percutaneous nephrostomy, or even
carrying out pyeloplasty if indicated.<span class="citation"><sup><a href="#ref-Stoffel2017" role="doc-biblioref">35</a>–<a href="#ref-Flukes2015" role="doc-biblioref">39</a></sup></span></p>
<p>Applying different management approach by categorizing the patient into
high-risk and non high-risk group posit better clinical outcomes.
Categorization is done based on signs and symptoms as well as laboratory and
radiographic findings. In this review, only high-risk group is of interest
since this group encompasses subjects with hydronephrosis. Asides from
diagnosed as having hydronephrosis, high risk patients also include those who
complain overflow urinary incontinence, are diagnosed with Chronic Kidney
Disease (CKD) and have estimated Glomerular Filtration Rate (eGFR) around
30-44%, experience urosepsis during the last six months and have recurrent
symptomatic Urinary Tract Infection (UTI) more than three times within the past
12 months.<span class="citation"><sup><a href="#ref-Stoffel2017" role="doc-biblioref">35</a></sup></span></p>
<p>In managing high-risk group, we may want to start from less invasive treatment
to release the built-up pressure due to urinary retention. Initial treatment
can be done by inserting a urinary or suprapubic catheter to reduce retained
urine. Risk reduction can also be done by starting specific medication, i.e
treat UTI with antibiotics. In this step, should the patient does not get any
improvement, we may also need to consider surgical intervention.<span class="citation"><sup><a href="#ref-Stoffel2017" role="doc-biblioref">35</a></sup></span></p>
<p>Afterwards, reassessment can be done by performing physical examination and
renal USG to confirm hydronephrosis, urine microscopy or culture to assert
infection and eGFR to affirm CKD. Urodynamic should also be considered if we
want to assess treatment efficacy on the underlying cause of hydronephrosis,
for instances Bladder Outlet Obstruction, Bladder Compliance and Vesicoureteral
Reflux.<span class="citation"><sup><a href="#ref-Stoffel2017" role="doc-biblioref">35</a></sup></span></p>
</div>
<div id="prognosis-of-hydronephrosis" class="section level2">
<h2>Prognosis of Hydronephrosis</h2>
<p>The clinical outcome of hydronephrosis is highly influenced by its underlying
condition, where patients with certain diagnosis may have different prognosis
compared to the other.<span class="citation"><sup><a href="#ref-Kurata2016" role="doc-biblioref">14</a>,<a href="#ref-deSousaMorais2018" role="doc-biblioref">40</a></sup></span> Being described in this
paper are three perspective on viewing the prognosis, namely <em>ad vitam</em>, <em>ad
functionam</em> and <em>ad sanationam</em>. <em>Ad vitam</em> explains the impact of
hydronephrosis on overall chance of survival. Meanwhile, <em>ad functionam</em>
defines the functional outcome of nephrons following physical insult due to
increased pressure in the presence of hydronephrosis. Lastly, <em>ad sanationam</em>
describes the recurrence rate of hydronephrosis based on its underlying
problem.</p>
<div id="ad-vitam" class="section level3">
<h3><em>Ad Vitam</em></h3>
<p>Cervical malignancy preceding the case of hydronephrosis is a predictive factor
for higher morbidity and mortality, even with adequate treatment.<span class="citation"><sup><a href="#ref-Patel2014" role="doc-biblioref">22</a>,<a href="#ref-Pradhan2011" role="doc-biblioref">23</a></sup></span> In this condition, the presence of hydronephrosis is usually
accompanied by reduced renal function, which may impede the drug excretion.
Moreover, drug dose adjustment may be required, thus increasing the risk of
being suboptimally treated.<span class="citation"><sup><a href="#ref-Patel2014" role="doc-biblioref">22</a></sup></span></p>
</div>
<div id="ad-functionam" class="section level3">
<h3><em>Ad Functionam</em></h3>
<p>In the case of obstructive hydronephrosis, prompt treatment of its underlying
cause may yield beneficial outcome for the patient. Should the underlying cause
get resolved while maintaining GFR &gt; 10mL/min/1.73m<sup>2</sup>, patients will more
likely to have favourable prognosis. Within such condition, renal injury can be
completely or partially resolved.<span class="citation"><sup><a href="#ref-Byers2018" role="doc-biblioref">12</a></sup></span></p>
<p>Albeit the result obtained by Hoshino, et al. might be confounded by age of
participants, lower creatinine clearance rate can be found in subjects with
higher grade hydronephrosis. In this study, lower grade hydronephrosis can
present creatinine clearance rate <span class="math inline">\(\geq\)</span> 50mL/min.<span class="citation"><sup><a href="#ref-Hoshino2012" role="doc-biblioref">41</a></sup></span> Denoting a
deteriorative facet of hydronephrosis, this result is also strongly supported
by another study, where silent ureter stone may lead to hydronephrosis and
irreversible renal function decline.<span class="citation"><sup><a href="#ref-Marchini2016" role="doc-biblioref">20</a></sup></span> Decline of function is
mostly related to the decaying persitaltic activity, whereas in Hydronephrotic
patients is found to be significantly lower compared to control group. Lower
peristaltic movement happened due to reduced number of Cajal-like cells along
lamina propria and muscularis propria.<span class="citation"><sup><a href="#ref-Balikci2015" role="doc-biblioref">21</a></sup></span></p>
<p>Hydronephrosis grading is also a good predictor for stone detection, where
urinary stone is found to be more prevalent in higher grade
hydronephrosis.<span class="citation"><sup><a href="#ref-Alshoabi2018" role="doc-biblioref">42</a></sup></span> This finding support a study by Amini, et al.
where the concentration of Carbohydrate Antigen (CA) 19-9 is proposed as a
potential biomarker for detecting renal damage associated with obstructive
uropathy in patients with urinary stones and hydronephrosis. In his study, CA
19-9 concentration is elevated during insulting period due to increased
pressure caused by urinary retention.<span class="citation"><sup><a href="#ref-Amini2016" role="doc-biblioref">43</a></sup></span></p>
<p>During the event of hydronephrosis, function of affected kidney could be
compromised,<span class="citation"><sup><a href="#ref-Byers2018" role="doc-biblioref">12</a></sup></span> leading to temporary functional cessation. Should it
be further aggravated, such condition may persist as an Acute Kidney Injury
(AKI).<span class="citation"><sup><a href="#ref-Rahman2012" role="doc-biblioref">44</a>–<a href="#ref-Gosmanova2009" role="doc-biblioref">46</a></sup></span> As a response of systemic
stress in a critical condition on AKI, erythropoietin is released stimulated by
IGFBP-1. However, no evidence supporting the presence of erythropoietin and
increasing haemoglobin in patients with AKI.<span class="citation"><sup><a href="#ref-Yamashita2016" role="doc-biblioref">47</a></sup></span> Hence, alteration
of haemoglobin concentration might not be a reliable marker in predicting
clinical outcome of hydronephrosis.</p>
<p>Kidney Injury Molecule-1 (KIM-1) is also proposed as a potential biomarker for
hydronephrosis and obstructive nephropahty-induced AKI.<span class="citation"><sup><a href="#ref-OlveraPosada2017" role="doc-biblioref">48</a>–<a href="#ref-Jin2017" role="doc-biblioref">50</a></sup></span>. Urinary concentration of KIM-1 is found to be
significantly higher in urinary stone patients with hydronephrosis as compared
to urinary stone patients without hydronephrosis.<span class="citation"><sup><a href="#ref-OlveraPosada2017" role="doc-biblioref">48</a></sup></span> In a
recent meta-analysis, utilization of KIM-1 to detect AKI demonstrated an area
under the curve of 0.86.<span class="citation"><sup><a href="#ref-Shao2014" role="doc-biblioref">49</a></sup></span> In an animal model, urine concentration of
KIM-1 followed a time-dependent increase, reflecting AKI progression in
unilateral urinary obstruction group.<span class="citation"><sup><a href="#ref-Jin2017" role="doc-biblioref">50</a></sup></span></p>
<p>Cortical thinning is another signs that can be radiographically observed in
patients with hydronephrosis.<span class="citation"><sup><a href="#ref-Hansen2015" role="doc-biblioref">51</a></sup></span> Reduction of cortical thickness may
reflect atrophy in hydronephrosis pathogenesis.<span class="citation"><sup><a href="#ref-Byers2018" role="doc-biblioref">12</a></sup></span> Thinner cortical
structure also impacts the overall function of the kidney, marked by decreasing
GFR (r=0.478; p&lt;0.001).<span class="citation"><sup><a href="#ref-Yamashita2015" role="doc-biblioref">52</a></sup></span> In the aforementioned study, the range
of upper third cortical thickness is 0.38 – 1.36cm and the range of middle third
cortical thickness is 0.37 – 1.18cm. From the same study, no statistical
correlation has been found between parenchymal thickness and the GFR.<span class="citation"><sup><a href="#ref-Yamashita2015" role="doc-biblioref">52</a></sup></span></p>
</div>
<div id="ad-sanationam" class="section level3">
<h3><em>Ad Sanationam</em></h3>
<p>Hydronephrotic patients with gastrointestinal cancer is less compliant to
ureteral stent treatment and more prone to experience stent
failure. In such cases, performing percutaneous nephrostomy would yield a
better result.<span class="citation"><sup><a href="#ref-Ohtaka2018" role="doc-biblioref">53</a></sup></span> Hydronephrosis grading has also been found associated
with non-organ-confined ureteric cancer as well as bladder cancer
recurrence.<span class="citation"><sup><a href="#ref-Luo2013" role="doc-biblioref">24</a></sup></span></p>
</div>
</div>
</div>
<div id="conclusion" class="section level1">
<h1>Conclusion</h1>
<p>Hydronephrosis is a clinical finding hallmarked by the presence of dilated
pelvis and its calyces. It can arise due to myriad factors which can be
categorized into obstructive and nonobstructive origin. Holistic treatment of
hydronephrosis requires physician to address the underlying cause.
Symptomatically, such treatment can be achieved by reducing the urinary
retention, thus minimizing the dilation. Prognosis of such treatment can be
predicted by several factors. The absence of malignancy underlying
hydronephrosis, prompt treatment while maintaining GFR &gt; 10mL/min/1.73m<sup>2</sup>,
creatinine clearance rate <span class="math inline">\(\geq\)</span> 50mL/min, low CA 19-9, low urinary KIM-1
concentration and thick cortical structure are predictors of good clinical
outcome. However, not enough evidence has been found to eliminate or confirm
haemoglobin as another potential biomarker.</p>
</div>
<div id="reference" class="section level1">
<h1>Reference</h1>
<div id="refs" class="references csl-bib-body">
<div id="ref-Mevorach2007" class="csl-entry">
<div class="csl-left-margin">1. </div><div class="csl-right-inline">Mevorach RA, Hulbert WC, Rabinowitz R. <a href="https://doi.org/10.1016/b978-032303506-4.10159-2">Hydronephrosis</a>. In: Pediatric clinical advisor. Elsevier; 2007. p. 283–4. </div>
</div>
<div id="ref-Murnaghan1958" class="csl-entry">
<div class="csl-left-margin">2. </div><div class="csl-right-inline">Murnaghan GF. <a href="https://doi.org/10.1136/pgmj.34.389.143">The physiology of hydronephrosis</a>. Postgraduate Medical Journal. 1958 Mar;34(389):143–8. </div>
</div>
<div id="ref-Roshani2003" class="csl-entry">
<div class="csl-left-margin">3. </div><div class="csl-right-inline">Roshani H. "Dynamics and modulation of ureteric peristalsis" [PhD thesis]. [Spui 21, 1012 WX Amsterdam, The Netherlands]: University of Amsterdam; 2003. </div>
</div>
<div id="ref-Vaidyanathan2012" class="csl-entry">
<div class="csl-left-margin">4. </div><div class="csl-right-inline">Vaidyanathan S, Selmi F, Abraham KA, Hughes P, Singh G, Soni B. <span class="nocase"><span>H</span>ydronephrosis and renal failure following inadequate management of neuropathic bladder in a patient with spinal cord injury: <span>C</span>ase report of a preventable complication</span>. Patient Saf Surg. 2012 Sep;6(1):22. </div>
</div>
<div id="ref-Choi2015" class="csl-entry">
<div class="csl-left-margin">5. </div><div class="csl-right-inline">Choi JI, Yoo JG, Kim SJ, Lee HN, Kim MJ. <a href="https://doi.org/10.1155/2015/761348">Acute renal failure due to obstructive uropathy secondary to ureteral endometriosis</a>. Case Reports in Obstetrics and Gynecology. 2015;2015:1–4. </div>
</div>
<div id="ref-Zambon2018" class="csl-entry">
<div class="csl-left-margin">6. </div><div class="csl-right-inline">Zambon JP, Koslov DS, Mihai B, Badlani GH. <a href="https://doi.org/10.1016/j.urology.2017.11.049">Bladder and ureteral dysfunction leading to hydronephrosis and hydroureteronephrosis in adults</a>. Urology. 2018 Jul;117:1–8. </div>
</div>
<div id="ref-Tran2014" class="csl-entry">
<div class="csl-left-margin">7. </div><div class="csl-right-inline">Tran VH, Nelson M, Nogar J, Bramante R. <a href="https://doi.org/10.5811/westjem.2014.4.20571">Bilateral hydronephrosis and cystitis resulting from chronic ketamine abuse</a>. Western Journal of Emergency Medicine. 2014 Jul;15(4):382–4. </div>
</div>
<div id="ref-Hui2011" class="csl-entry">
<div class="csl-left-margin">8. </div><div class="csl-right-inline">Hui SYA, Chan SCS, Lam SYJ, Lau TK, Chung KHT. <a href="https://doi.org/10.1007/s00192-011-1504-2">A prospective study on the prevalence of hydronephrosis in women with pelvic organ prolapse and their outcomes after treatment</a>. International Urogynecology Journal. 2011 Aug;22(12):1529–34. </div>
</div>
<div id="ref-Dancz2015" class="csl-entry">
<div class="csl-left-margin">9. </div><div class="csl-right-inline">Dancz CE, Walker D, Thomas D, Özel B. <a href="https://doi.org/10.1016/j.urology.2015.05.005">Prevalence of hydronephrosis in women with advanced pelvic organ prolapse</a>. Urology. 2015 Aug;86(2):250–4. </div>
</div>
<div id="ref-Nuraj2017" class="csl-entry">
<div class="csl-left-margin">10. </div><div class="csl-right-inline">Nuraj P, Hyseni N. <a href="https://doi.org/10.5455/aim.2017.25.178-181">The diagnosis of obstructive hydronephrosis with color doppler ultrasound</a>. Acta Informatica Medica. 2017;25(3):178. </div>
</div>
<div id="ref-Riyach2014" class="csl-entry">
<div class="csl-left-margin">11. </div><div class="csl-right-inline">Riyach O, Ahsaini M, Kharbach Y, Bounoual M, Tazi MF, Ammari JEE, et al. <a href="https://doi.org/10.1186/1752-1947-8-42">Bilateral ureteral obstruction revealing a benign prostatic hypertrophy: A case report and review of the literature</a>. Journal of Medical Case Reports. 2014 Feb;8(1). </div>
</div>
<div id="ref-Byers2018" class="csl-entry">
<div class="csl-left-margin">12. </div><div class="csl-right-inline">Byers LA, Rochon PJ. <a href="https://doi.org/10.1007/978-3-319-71300-7_43">Obstructive uropathy</a>. In: <span>IR</span> playbook. Springer International Publishing; 2018. p. 477–87. </div>
</div>
<div id="ref-Lojanapiwat2002" class="csl-entry">
<div class="csl-left-margin">13. </div><div class="csl-right-inline">Lojanapiwat B, Sripralakrit S, Soonthornphan S, Wudhikarn S. <a href="https://doi.org/10.1016/s1015-9584(09)60181-0">Intravesicle formalin instillation with a modified technique for controlling haemorrhage secondary to radiation cystitis</a>. Asian Journal of Surgery. 2002 Jul;25(3):232–5. </div>
</div>
<div id="ref-Kurata2016" class="csl-entry">
<div class="csl-left-margin">14. </div><div class="csl-right-inline">Kurata S, Tobu S, Udo K, Noguchi M. <a href="https://doi.org/10.1159/000447165">Outcomes of ureteral stent placement for hydronephrosis in patients with gynecological malignancies</a>. Current Urology. 2016;10(3):126–31. </div>
</div>
<div id="ref-Orchard2016" class="csl-entry">
<div class="csl-left-margin">15. </div><div class="csl-right-inline">Orchard J, Tward JD, Lenherr S, Hotaling JM, Brant WO, Myers JB. <a href="https://doi.org/10.1016/j.eucr.2016.03.003">Surgical management of ureteral strictures arising from radiotherapy for prostate cancer</a>. Urology Case Reports. 2016 May;6:47–9. </div>
</div>
<div id="ref-Fernbach1993" class="csl-entry">
<div class="csl-left-margin">16. </div><div class="csl-right-inline">Fernbach SK, Maizels M, Conway JJ. <a href="https://doi.org/10.1007/bf02012459">Ultrasound grading of hydronephrosis: Introduction to the system used by the society for fetal urology</a>. Pediatric Radiology. 1993 Oct;23(6):478–80. </div>
</div>
<div id="ref-Jespersen2005" class="csl-entry">
<div class="csl-left-margin">17. </div><div class="csl-right-inline">Jespersen B, Østraat Øyvind. <a href="https://doi.org/10.1093/ndt/gfh682">Recurrent hydronephrosis causing acute uraemia in a renal transplant donor without the presence of stones or stricture</a>. Nephrology Dialysis Transplantation. 2005 Mar;20(5):1017–8. </div>
</div>
<div id="ref-Zhu2012" class="csl-entry">
<div class="csl-left-margin">18. </div><div class="csl-right-inline">Zhu JXG, Gabril MY, Sener A. <a href="https://doi.org/10.5489/cuaj.11033">A rare case of recurrent urinary obstruction and acute renal failure from cystitis cystica et glandularis</a>. Canadian Urological Association Journal. 2012 Apr;6(2):72–4. </div>
</div>
<div id="ref-Chiancone2017" class="csl-entry">
<div class="csl-left-margin">19. </div><div class="csl-right-inline">Chiancone F, Fedelini M, Pucci L, Meccariello C, Fedelini P. <a href="https://doi.org/10.1590/s1677-5538.ibju.2016.0198">Laparoscopic management of recurrent ureteropelvic junction obstruction following pyeloplasty: A single surgical team experience with 38 cases</a>. International braz j urol. 2017 Jun;43(3):512–7. </div>
</div>
<div id="ref-Marchini2016" class="csl-entry">
<div class="csl-left-margin">20. </div><div class="csl-right-inline">Marchini GS, Vicentini FC, Monga M, Torricelli FC, Danilovic A, Brito AH, et al. <a href="https://doi.org/10.1016/j.urology.2016.02.042">Irreversible renal function impairment due to silent ureteral stones</a>. Urology. 2016 Jul;93:33–9. </div>
</div>
<div id="ref-Balikci2015" class="csl-entry">
<div class="csl-left-margin">21. </div><div class="csl-right-inline">Balikci Ö, Turunç T, Bal N, Çelik H, Özkardeş H. <a href="https://doi.org/10.1590/s1677-5538.ibju.2014.0427">Comparison of cajal-like cells in pelvis and proximal ureter of kidney with and without hydronephrosis</a>. International braz j urol. 2015 Dec;41(6):1178–84. </div>
</div>
<div id="ref-Patel2014" class="csl-entry">
<div class="csl-left-margin">22. </div><div class="csl-right-inline">Patel K, Foster NR, Kumar A, Grudem M, Longenbach S, Bakkum-Gamez J, et al. <a href="https://doi.org/10.1007/s00520-014-2482-y">Hydronephrosis in patients with cervical cancer: An assessment of morbidity and survival</a>. Supportive Care in Cancer. 2014 Oct;23(5):1303–9. </div>
</div>
<div id="ref-Pradhan2011" class="csl-entry">
<div class="csl-left-margin">23. </div><div class="csl-right-inline">Pradhan TS, Duan H, Katsoulakis E, Salame G, Lee Y-C, Abulafia O. <a href="https://doi.org/10.1097/igc.0b013e31821cabc8">Hydronephrosis as a prognostic indicator of survival in advanced cervix cancer</a>. International Journal of Gynecological Cancer. 2011 Aug;21(6):1091–6. </div>
</div>
<div id="ref-Luo2013" class="csl-entry">
<div class="csl-left-margin">24. </div><div class="csl-right-inline">Luo HL, Kang CH, Chen YT, Chuang YC, Lee WC, Cheng YT, et al. <a href="https://doi.org/10.1111/bju.12157">Severity of hydronephrosis correlates with tumour invasiveness and urinary bladder recurrence of ureteric cancer</a>. <span>BJU</span> International. 2013 Jun;112(4):489–94. </div>
</div>
<div id="ref-Koeppen2013" class="csl-entry">
<div class="csl-left-margin">25. </div><div class="csl-right-inline">Koeppen BM, Stanton BA. Glomerular filtration and renal blood flow. In: Renal physiology [Internet]. Elsevier; 2013. p. 27–43. Available from: <a href="https://doi.org/10.1016/b978-0-323-08691-2.00003-x">https://doi.org/10.1016/b978-0-323-08691-2.00003-x</a></div>
</div>
<div id="ref-Carlstrom2015" class="csl-entry">
<div class="csl-left-margin">26. </div><div class="csl-right-inline">Carlström M, Wilcox CS, Arendshorst WJ. <a href="https://doi.org/10.1152/physrev.00042.2012">Renal autoregulation in health and disease</a>. Physiological Reviews. 2015 Apr;95(2):405–511. </div>
</div>
<div id="ref-Nguyen2016" class="csl-entry">
<div class="csl-left-margin">27. </div><div class="csl-right-inline">Nguyen MJ, Higashi R, Ohta K, Nakamura K-I, Hashitani H, Lang RJ. Autonomic and sensory nerve modulation of peristalsis in the upper urinary tract. Autonomic Neuroscience [Internet]. 2016 Oct;200:1–0. Available from: <a href="https://doi.org/10.1016/j.autneu.2015.07.425">https://doi.org/10.1016/j.autneu.2015.07.425</a></div>
</div>
<div id="ref-Davidson2000" class="csl-entry">
<div class="csl-left-margin">28. </div><div class="csl-right-inline">Davidson ME, Lang RJ. Effects of selective inhibitors of cyclo-oxygenase-1 (<span>COX</span>-1) and cyclo-oxygenase-2 (<span>COX</span>-2) on the spontaneous myogenic contractions in the upper urinary tract of the guinea-pig and rat. British Journal of Pharmacology [Internet]. 2000 Feb;129(4):661–70. Available from: <a href="https://doi.org/10.1038/sj.bjp.0703104">https://doi.org/10.1038/sj.bjp.0703104</a></div>
</div>
<div id="ref-AitchisonSmith2018" class="csl-entry">
<div class="csl-left-margin">29. </div><div class="csl-right-inline">Smith DA. <a href="https://doi.org/10.1007/978-3-030-03526-6_7">Models of thin-filament regulation</a>. In: The sliding-filament theory of muscle contraction. Springer International Publishing; 2018. p. 293–346. </div>
</div>
<div id="ref-Aboutaleb2003" class="csl-entry">
<div class="csl-left-margin">30. </div><div class="csl-right-inline">Aboutaleb H, Bolduc S, Bagli DJ, Khoury AE. <a href="https://doi.org/10.1097/01.ju.0000084334.10480.88">Correlation of vesicoureteral reflux with degree of hydronephrosis and the impact of antireflux surgery</a>. Journal of Urology. 2003 Oct;170(4 Part 2):1560–2. </div>
</div>
<div id="ref-Cotter2016" class="csl-entry">
<div class="csl-left-margin">31. </div><div class="csl-right-inline">Cotter KJ, Levy ME, Goldfarb RA, Liberman D, Katorski J, Myers JB, et al. <a href="https://doi.org/10.1016/j.urology.2016.05.024">Urodynamic findings in adults with moderate to severe cerebral palsy</a>. Urology. 2016 Sep;95:216–21. </div>
</div>
<div id="ref-Downs2014" class="csl-entry">
<div class="csl-left-margin">32. </div><div class="csl-right-inline">Downs J, Wolfe T, Walker H. <a href="https://doi.org/10.1179/2045772314y.0000000211">Development of hydronephrosis secondary to poorly managed neurogenic bowel requiring surgical disimpaction in a patient with spinal cord injury: A case report</a>. The Journal of Spinal Cord Medicine. 2014 Mar;37(6):795–8. </div>
</div>
<div id="ref-Stoffel2016" class="csl-entry">
<div class="csl-left-margin">33. </div><div class="csl-right-inline">Stoffel JT. <span class="nocase"><span>D</span>etrusor sphincter dyssynergia: a review of physiology, diagnosis, and treatment strategies</span>. Transl Androl Urol. 2016 Feb;5(1):127–35. </div>
</div>
<div id="ref-Gormley2010" class="csl-entry">
<div class="csl-left-margin">34. </div><div class="csl-right-inline">Gormley EA. <a href="https://doi.org/10.1016/j.ucl.2010.07.002">Urologic complications of the neurogenic bladder</a>. Urologic Clinics of North America. 2010 Nov;37(4):601–7. </div>
</div>
<div id="ref-Stoffel2017" class="csl-entry">
<div class="csl-left-margin">35. </div><div class="csl-right-inline">Stoffel JT, Peterson AC, Sandhu JS, Suskind AM, Wei JT, Lightner DJ. <a href="https://doi.org/10.1016/j.juro.2017.01.075"><span>AUA</span> white paper on nonneurogenic chronic urinary retention: Consensus definition, treatment algorithm, and outcome end points</a>. Journal of Urology. 2017 Jul;198(1):153–60. </div>
</div>
<div id="ref-Nayyar2016" class="csl-entry">
<div class="csl-left-margin">36. </div><div class="csl-right-inline">Nayyar R, Yadav S, Singh P, Kumar R, Seth A, Dogra PN. <a href="https://doi.org/10.1016/j.urology.2016.02.045">Outcomes of pyeloplasty in very poorly functioning kidneys: Examining the myths</a>. Urology. 2016 Jun;92:132–5. </div>
</div>
<div id="ref-Dagli2011" class="csl-entry">
<div class="csl-left-margin">37. </div><div class="csl-right-inline">Dagli M, Ramchandani P. <a href="https://doi.org/10.1055/s-0031-1296085">Percutaneous nephrostomy: Technical aspects and indications</a>. Seminars in Interventional Radiology. 2011 Dec;28(04):424–37. </div>
</div>
<div id="ref-Patel2017" class="csl-entry">
<div class="csl-left-margin">38. </div><div class="csl-right-inline">Patel C, Loughran D, Jones R, Abdulmajed M, Shergill I. <a href="https://doi.org/10.1186/s12894-017-0204-8">The resonance<span></span> metallic ureteric stent in the treatment of chronic ureteric obstruction: A safety and efficacy analysis from a contemporary clinical series</a>. <span>BMC</span> Urology. 2017 Mar;17(1). </div>
</div>
<div id="ref-Flukes2015" class="csl-entry">
<div class="csl-left-margin">39. </div><div class="csl-right-inline">Flukes S, Hayne D, Kuan M, Wallace M, McMillan K, Rukin NJ. <a href="https://doi.org/10.1111/bju.12918">Retrograde ureteric stent insertion in the management of infected obstructed kidneys</a>. <span>BJU</span> International. 2015 Apr;115:31–4. </div>
</div>
<div id="ref-deSousaMorais2018" class="csl-entry">
<div class="csl-left-margin">40. </div><div class="csl-right-inline">Sousa Morais N de, Pereira JP, Mota P, Carvalho-Dias E, Torres JN, Lima E. <a href="https://doi.org/10.1007/s00240-018-1078-2">Percutaneous nephrostomy vs ureteral stent for hydronephrosis secondary to ureteric calculi: Impact on spontaneous stone passage and health-related quality of life<span></span>a prospective study</a>. Urolithiasis. 2018 Sep; </div>
</div>
<div id="ref-Hoshino2012" class="csl-entry">
<div class="csl-left-margin">41. </div><div class="csl-right-inline">Hoshino K, Kikuchi E, Tanaka N, Akita H, Ito Y, Miyajima A, et al. <a href="https://doi.org/10.1093/jjco/hyr199">Preoperative hydronephrosis: Independent predictor for changes in renal function following nephroureterectomy</a>. Japanese Journal of Clinical Oncology. 2012 Jan;42(3):202–7. </div>
</div>
<div id="ref-Alshoabi2018" class="csl-entry">
<div class="csl-left-margin">42. </div><div class="csl-right-inline">Alshoabi SA. <a href="https://doi.org/10.12669/pjms.344.14602">Association between grades of hydronephrosis <span>&amp;</span> detection of urinary stones by ultrasound imaging</a>. Pakistan Journal of Medical Sciences. 2018 Jul;34(4). </div>
</div>
<div id="ref-Amini2016" class="csl-entry">
<div class="csl-left-margin">43. </div><div class="csl-right-inline">Amini E, Pishgar F, Hojjat A, Soleimani M, Asgari MA, Kajbafzadeh A-M. <a href="https://doi.org/10.1080/0886022x.2016.1202732">The role of serum and urinary carbohydrate antigen 19-9 in predicting renal injury associated with ureteral stone</a>. Renal Failure. 2016 Oct;38(10):1626–32. </div>
</div>
<div id="ref-Rahman2012" class="csl-entry">
<div class="csl-left-margin">44. </div><div class="csl-right-inline">Rahman M, Shad F, Smith MC. <span class="nocase"><span>A</span>cute kidney injury: a guide to diagnosis and management</span>. Am Fam Physician. 2012 Oct;86(7):631–9. </div>
</div>
<div id="ref-Sandberg2017" class="csl-entry">
<div class="csl-left-margin">45. </div><div class="csl-right-inline">Sandberg JM, Dyer RB, Mirzazadeh M. <a href="https://doi.org/10.1089/cren.2017.0063">A rare case report of hydronephrosis and acute kidney injury secondary to gonadal vein thrombosis in a young male</a>. Journal of Endourology Case Reports. 2017 Dec;3(1):119–22. </div>
</div>
<div id="ref-Gosmanova2009" class="csl-entry">
<div class="csl-left-margin">46. </div><div class="csl-right-inline">Gosmanova EO, Baumgarten DA, O’Neill WC. <a href="https://doi.org/10.1053/j.ajkd.2009.03.028">Acute kidney injury in a patient with unilateral ureteral obstruction</a>. American Journal of Kidney Diseases. 2009 Oct;54(4):775–9. </div>
</div>
<div id="ref-Yamashita2016" class="csl-entry">
<div class="csl-left-margin">47. </div><div class="csl-right-inline">Yamashita T, Noiri E, Hamasaki Y, Matsubara T, Ishii T, Yahagi N, et al. <a href="https://doi.org/10.1111/nep.12656">Erythropoietin concentration in acute kidney injury is associated with insulin-like growth factor-binding protein-1</a>. Nephrology. 2016 Jul;21(8):693–9. </div>
</div>
<div id="ref-OlveraPosada2017" class="csl-entry">
<div class="csl-left-margin">48. </div><div class="csl-right-inline">Olvera-Posada D, Dayarathna T, Dion M, Alenezi H, Sener A, Denstedt JD, et al. <a href="https://doi.org/10.1089/end.2016.0215"><span>KIM</span>-1 is a potential urinary biomarker of obstruction: Results from a prospective cohort study</a>. Journal of Endourology. 2017 Feb;31(2):111–8. </div>
</div>
<div id="ref-Shao2014" class="csl-entry">
<div class="csl-left-margin">49. </div><div class="csl-right-inline">Shao X, Tian L, Xu W, Zhang Z, Wang C, Qi C, et al. <a href="https://doi.org/10.1371/journal.pone.0084131">Diagnostic value of urinary kidney injury molecule 1 for acute kidney injury: A meta-analysis</a>. Bruns H, editor. <span>PLoS</span> <span>ONE</span>. 2014 Jan;9(1):e84131. </div>
</div>
<div id="ref-Jin2017" class="csl-entry">
<div class="csl-left-margin">50. </div><div class="csl-right-inline">Jin Y, Shao X, Sun B, Miao C, Li Z, Shi Y. <a href="https://doi.org/10.3892/mmr.2017.6103">Urinary kidney injury molecule-1 as an early diagnostic biomarker of obstructive acute kidney injury and development of a rapid detection method</a>. Molecular Medicine Reports. 2017 Jan;15(3):1229–35. </div>
</div>
<div id="ref-Hansen2015" class="csl-entry">
<div class="csl-left-margin">51. </div><div class="csl-right-inline">Hansen K, Nielsen M, Ewertsen C. <a href="https://doi.org/10.3390/diagnostics6010002">Ultrasonography of the kidney: A pictorial review</a>. Diagnostics. 2015 Dec;6(1):2. </div>
</div>
<div id="ref-Yamashita2015" class="csl-entry">
<div class="csl-left-margin">52. </div><div class="csl-right-inline">Yamashita SR, Atzingen AC von, Iared W, Araújo Bezerra AS de, Ammirati AL, Canziani MEF, et al. <a href="https://doi.org/10.1590/0100-3984.2014.0008">Value of renal cortical thickness as a predictor of renal function impairment in chronic renal disease patients</a>. Radiologia Brasileira. 2015 Feb;48(1):12–6. </div>
</div>
<div id="ref-Ohtaka2018" class="csl-entry">
<div class="csl-left-margin">53. </div><div class="csl-right-inline">Ohtaka M, Kawahara T, Takamoto D, Mochizuki T, Hattori Y, Teranishi J, et al. <a href="https://doi.org/10.1186/s12894-018-0346-3">Gastrointestinal cancer and bilateral hydronephrosis resulted in a high risk of ureteral stent failure</a>. <span>BMC</span> Urology. 2018 May;18(1). </div>
</div>
</div>
</div>
